April 2019: Results From SC+ Human Factors Testing Published In Hemodialysis International

Quanta Dialysis Technologies, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that results from its human factors testing (HFT) of SC+ have been published in Hemodialysis International, a leading peer-reviewed journal for the renal community. SC+ was designed to empower patients to take control of their lives by making selfcare and home haemodialysis more accessible through a device that is small, simple to use, and powerful enough to deliver dialysis adequacy. This addresses the need for a dialysis system that is appealing to patients while also being suitable for use across the continuum of care, from the clinic to the home.

Click Here To Read The Full Press Release


March 2019: Quanta To Present At The 39th Annual Dialysis Conference

Quanta Dialysis Technologies, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that the Company will be presenting at the 39th Annual Dialysis Conference (ADC), which runs from 16 to 19 March 2019, at the Sheraton Dallas Hotel, Texas, USA. Dr. Paul Komenda, Chief Medical Officer, will provide an update on SC+, explaining how it enables choice, efficiency and empowerment to both patients and physicians in the "Home Dialysis Machines" session on Monday, 18 March at 3:00pm. The presentation will be followed by a device demonstration at 3:45pm.

Click Here To Read The Full Press Release


February 2019: Quanta Strengthens Management Team In Preparation For Launch of SC+

Quanta Dialysis Technologies, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces the expansion of its management team with the appointment of Steve Lane as Commercial Director, Chanel Allen-Megahey as Global Quality Assurance and Regulatory Affairs Director and Frank Herrmann as Marketing Director.

Click Here To Read The Full Press Release


January 2019: Quanta Appoints Dr. Paul Komenda As New Chief Medical Officer

Quanta Dialysis Technologies, today announces that the Company has appointed Dr. Paul Komenda as Chief Medical Officer. Dr. Komenda, Associate Professor of Medicine at the University of Manitoba, is a fellow of the American Society of Nephrology and has extensive clinical and academic experience. Dr. Komenda previously served on the Scientific Advisory Board of NxStage Medical. He gained his medical qualification in 2001 from the University of Manitoba and is a board certified Nephrologist. Dr. Komenda studied health economics at the University of Calgary, holds a Masters in Health Administration and is also the Medical Director of the Home Dialysis Program and the Seven Oaks General Hospital in Manitoba.

Click Here To Read The Full Press Release


View our past press releases